WHO ICTRP trial
The efficacy of tranexamic acid which is a drug that promotes clotting of blood…
CTRI/2021/09/036855 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2021/09/036855 |
|---|---|
| Public title | The efficacy of tranexamic acid which is a drug that promotes clotting of blood, in preventing blood loss in patients undergoing surgeries in and around hip joint |
| Scientific title | Evaluation of efficacy of tranexamic acid on blood loss in periarticular hip surgeries |
| Primary sponsor | Pt BD Sharma PGIMS Rohtak |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: V00-Y99- External causes of morbidity |
| Interventions | Intervention1: Tranexamic acid: Tablets containing 1950mg of tranexamic acid given 2 hours prior to incision for surgery and 2g of injection tranexamic acid diluted in 20ml normal saline given through post operative drain. Control… |
| Registration date | Sep 27, 2021 |
| Target size | 100 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: